Dr Judith Boer on lymphoblastic leukaemia in children
The Lancet Haematology in conversation with
English - December 22, 2020 23:00 - 10 minutes - 7.18 MBLife Sciences Science Education blood haemophilia haematology leukaemia Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Imatinib for paediatric leukaemia
Next Episode: Nada Hamad on inclusion and diversity in haematology
Editor-in-Chief, Dr Lan-Lan Smith, speaks with Dr Judith Boer (Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands) about outcome of ABL-class acute lymphoblastic leukaemia in children in the pre-tyrosine kinase inhibitor era.
Read the full article:
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30353-7/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv